True “costs” of neurological illness in human immunodeficiency virus patients in a “free” health facility
- 1 July 2021
- journal article
- Published by Scientific Scholar in Indian Journal of Medical Sciences
- Vol. 73, 221-225
- https://doi.org/10.25259/ijms_285_2020
Abstract
Objectives: Human immunodeficiency virus (HIV) infection and neurological illness cause heavy financial burden to the patients. The economic costs of each of the disease have been reported in many studies, but the toll of both together on the patients has not been studied clearly. As neurological illnesses are seen in up to one-third of HIV patients, the combined costs need to be understood. Even with free public health services, there are out of pocket expenditures on the patients. Material and Methods: In the tertiary Government General Hospital, Guntur in India, we studied the out-of-pocket costs of time and money borne by 50 HIV-seropositive individuals hospitalized for a neurological illness during April and May 2019. We obtained data from the patients and caregivers by face-to-face oral questionnaires. Results: The median duration of HIV infection was 2.5 (IQR 0.4–7.8) years. A high proportion of our patients (20/50) was diagnosed with tuberculous meningitis. The total median time lost by each HIV-seropositive patient due to neurological illness (private consultation, travel, and hospital stay) was 27.5 (8.7–134.3) days. The total median financial burden due to neurological disease requiring hospitalization (travel, food and medicine, wages lost, private consultation expense, and loans incurred) on each patient was ₹19,150 (855–59881). Conclusion: HIV patients with neurological illness are burdened by heavy costs of time and money. They are forced into debt and lose substantial wages, most of it due to private consultation.Keywords
This publication has 13 references indexed in Scilit:
- Transport of pregnant women and obstetric emergencies in India: an analysis of the ‘108’ ambulance service system dataBMC Pregnancy and Childbirth, 2016
- Use of traditional medicine in middle-income countries: a WHO-SAGE studyHealth Policy and Planning, 2016
- Neurology in the developing worldHandbook of Clinical Neurology, 2014
- The size, burden and cost of disorders of the brain in the UKJournal of Psychopharmacology, 2013
- Universal health coverage: the third global health transition?The Lancet, 2012
- Traditional Indian medicine and homeopathy for HIV/AIDS: a review of the literatureAIDS Research and Therapy, 2008
- Costs and financial burden of care and support services to PLHA and households in South IndiaAIDS Care, 2006
- The private health sector in IndiaBMJ, 2005
- THE ECONOMIC BURDEN OF ILLNESS FOR HOUSEHOLDS IN DEVELOPING COUNTRIES: A REVIEW OF STUDIES FOCUSING ON MALARIA, TUBERCULOSIS, AND HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROMEThe American Journal of Tropical Medicine and Hygiene, 2004
- Household cost of seeking malaria care. A retrospective study of two districts in Ghana.Social Science & Medicine (1982), 1997